Tzeng Y, Sannigrahi S, Borrow R, Stephens D
Front Immunol. 2024; 15:1350344.
PMID: 38440731
PMC: 10909805.
DOI: 10.3389/fimmu.2024.1350344.
Brusletto B, Hellerud B, Ovstebo R, Brandtzaeg P
Front Cell Infect Microbiol. 2023; 13:1298360.
PMID: 38089821
PMC: 10713808.
DOI: 10.3389/fcimb.2023.1298360.
Mieszala M, Jennings H, Drab M, Gamian A
Arch Immunol Ther Exp (Warsz). 2019; 67(4):237-248.
PMID: 31030218
PMC: 6597602.
DOI: 10.1007/s00005-019-00542-9.
Mubaiwa T, Semchenko E, Hartley-Tassell L, Day C, Jennings M, Seib K
Pathog Dis. 2017; 75(5).
PMID: 28633281
PMC: 5808653.
DOI: 10.1093/femspd/ftx063.
Zariri A, Pupo E, van Riet E, van Putten J, Van der Ley P
Sci Rep. 2016; 6:36575.
PMID: 27841285
PMC: 5107901.
DOI: 10.1038/srep36575.
Utilizing complement evasion strategies to design complement-based antibacterial immunotherapeutics: Lessons from the pathogenic Neisseriae.
Ram S, Shaughnessy J, DeOliveira R, Lewis L, Gulati S, Rice P
Immunobiology. 2016; 221(10):1110-23.
PMID: 27297292
PMC: 4987187.
DOI: 10.1016/j.imbio.2016.05.016.
The biology of Neisseria adhesins.
Hung M, Christodoulides M
Biology (Basel). 2014; 2(3):1054-109.
PMID: 24833056
PMC: 3960869.
DOI: 10.3390/biology2031054.
Lipopolysaccharide engineering in Neisseria meningitidis: structural analysis of different pentaacyl lipid A mutants and comparison of their modified agonist properties.
Pupo E, Hamstra H, Meiring H, Van der Ley P
J Biol Chem. 2014; 289(12):8668-80.
PMID: 24492609
PMC: 3961689.
DOI: 10.1074/jbc.M114.554345.
Human lipooligosaccharide IGG that prevents endemic meningococcal disease recognizes an internal lacto-N-neotetraose structure.
Cheng H, Yang Z, Estabrook M, John C, Jarvis G, Mclaughlin S
J Biol Chem. 2011; 286(51):43622-43633.
PMID: 22027827
PMC: 3243514.
DOI: 10.1074/jbc.M111.291583.
Importance of antibodies to lipopolysaccharide in natural and vaccine-induced serum bactericidal activity against Neisseria meningitidis group B.
Schmiel D, Moran E, Keiser P, Brandt B, Zollinger W
Infect Immun. 2011; 79(10):4146-56.
PMID: 21768280
PMC: 3187254.
DOI: 10.1128/IAI.05125-11.
Genetic and structural characterization of L11 lipooligosaccharide from Neisseria meningitidis serogroup A strains.
Mistretta N, Seguin D, Thiebaud J, Vialle S, Blanc F, Brossaud M
J Biol Chem. 2010; 285(26):19874-83.
PMID: 20421293
PMC: 2888398.
DOI: 10.1074/jbc.M110.100636.
The transcriptional repressor FarR is not involved in meningococcal fatty acid resistance mediated by the FarAB efflux pump and dependent on lipopolysaccharide structure.
Schielke S, Schmitt C, Spatz C, Frosch M, Schubert-Unkmeir A, Kurzai O
Appl Environ Microbiol. 2010; 76(10):3160-9.
PMID: 20348314
PMC: 2869119.
DOI: 10.1128/AEM.02833-09.
Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response.
Weynants V, Denoel P, Devos N, Janssens D, Feron C, Goraj K
Infect Immun. 2009; 77(5):2084-93.
PMID: 19289516
PMC: 2681751.
DOI: 10.1128/IAI.01108-08.
Differential activation of human and mouse Toll-like receptor 4 by the adjuvant candidate LpxL1 of Neisseria meningitidis.
Steeghs L, Keestra A, van Mourik A, Uronen-Hansson H, Van der Ley P, Callard R
Infect Immun. 2008; 76(8):3801-7.
PMID: 18490457
PMC: 2493235.
DOI: 10.1128/IAI.00005-08.
Modeling Neisseria meningitidis metabolism: from genome to metabolic fluxes.
E Baart G, Zomer B, de Haan A, van der Pol L, Beuvery E, Tramper J
Genome Biol. 2007; 8(7):R136.
PMID: 17617894
PMC: 2323225.
DOI: 10.1186/gb-2007-8-7-r136.
Enhanced factor H binding to sialylated Gonococci is restricted to the sialylated lacto-N-neotetraose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in Gonococci.
Gulati S, Cox A, Lewis L, St Michael F, Li J, Boden R
Infect Immun. 2005; 73(11):7390-7.
PMID: 16239538
PMC: 1273834.
DOI: 10.1128/IAI.73.11.7390-7397.2005.
lpt6, a gene required for addition of phosphoethanolamine to inner-core lipopolysaccharide of Neisseria meningitidis and Haemophilus influenzae.
Wright J, Hood D, Randle G, Makepeace K, Cox A, Li J
J Bacteriol. 2004; 186(20):6970-82.
PMID: 15466050
PMC: 522187.
DOI: 10.1128/JB.186.20.6970-6982.2004.
Development, characterization, and functional activity of a panel of specific monoclonal antibodies to inner core lipopolysaccharide epitopes in Neisseria meningitidis.
Gidney M, Plested J, Lacelle S, Coull P, Wright J, Makepeace K
Infect Immun. 2003; 72(1):559-69.
PMID: 14688137
PMC: 351819.
DOI: 10.1128/IAI.72.1.559-569.2004.
Phosphorylation of the lipid A region of meningococcal lipopolysaccharide: identification of a family of transferases that add phosphoethanolamine to lipopolysaccharide.
Cox A, Wright J, Li J, Hood D, Moxon E, Richards J
J Bacteriol. 2003; 185(11):3270-7.
PMID: 12754224
PMC: 155371.
DOI: 10.1128/JB.185.11.3270-3277.2003.
Cross-reactive polyclonal antibodies to the inner core of lipopolysaccharide from Neisseria meningitidis.
Andersen S, Guthrie T, Guile G, Kolberg J, Hou S, Hyland L
Infect Immun. 2002; 70(3):1293-300.
PMID: 11854213
PMC: 127742.
DOI: 10.1128/IAI.70.3.1293-1300.2002.